Summarize Experience, Check Problems, Formulate Measures, Fully Deploy 2022 Work
Release time:
2022-02-08
News from our newspaper # February 25 and 26 , the group company held a business work analysis meeting to review and summarize the work situation in 2021 , arrange and deploy the work for the new year, and put forward work requirements. At the
meeting, various professional companies and directly affiliated enterprises made a report on the overall work situation of 2021 , focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and a work plan for 2021 . The functional departments and offices of the headquarters made a brief report on the annual work situation and the 2021 work plan. Xiang Chongping, deputy general manager of the group company, systematically combed the human resources development in 2021 from the current human resources structure, recruitment and resignation, training management, salary level and labor productivity, enterprise labor management, etc. Lan Xiaolong, head of finance, analyzed the company's profit and profit structure in 2021 , and pointed out the risk points that need attention in operation and management; chen Tianci, Chairman of the Board of Supervisors, analyzed the overall situation of technological transformation projects of various enterprises in the three years of 2019-2021 and the problems existing in the implementation process. Zhu Jianwei, secretary of the board of directors, analyzed the future risks that the company may encounter from the aspects of peak and listed companies in related industries in the year 2021 and the revision of listing rules. Yu Jianhong, general manager of
Group Company, made a comprehensive review of the company's operation in 2021 , made a comparative analysis of the main economic indicators of various industrial sectors, and pointed out that substantial progress has been made in the construction of key investment projects. Continue to strengthen management integration and effectively improve the management level; New achievements have been made in scientific and technological innovation and technological transformation. Overcoming the adverse effects of epidemic situation, power restriction and production restriction, efforts to expand sales; strengthen personnel training, selection and introduction, and optimize the salary system; to celebrate the centenary of the founding of the party and the study and education of party history as a starting point, strengthen party building and ideological and political construction, and enhance the cohesion and centripetal force of enterprises; strengthen the daily prevention and control of the new coronary pneumonia epidemic to ensure the safety and health of employees; and effectively enhance the corporate image, influence and reputation and other work highlights. In particular, the results of a series of technological transformation of Daye Peak are remarkable, many economic and technical indicators of Huang Ping Peak have reached the leading level in the industry, the market sales of Olopatadine Eye Drops, a new product of Peak Pharmaceutical, are progressing smoothly, and the legal work of the Office of the Board of Directors and the safety management measures of the Audit Performance Management Department are promoted. At the same time, it also focuses on some problems such as the decline in profit level, the slower-than-expected progress of new projects, the higher labor productivity of production lines, the insufficient innovation ability of research and development capability, the outdated ideas and thinking modes of management personnel, the unsatisfactory construction of talent team, and the rise of the phenomenon of "three violations " .
Based on the current macroeconomic situation and the future trends of various related industries, Yu Jianhong, on behalf of the Group, proposed the working policy of 2022 as "Reform, Breakthrough, Innovation, Development " , and around this policy, proposed the key work of 2022 , with emphasis, planning for the future development of "second curve " , breaking through the development bottleneck and quickly entering a new growth track is the company's current top priority. Under the company's existing system and mechanism, it is necessary to solve the three problems of development motivation, development concept and development ability, that is, to stimulate development motivation through cultural identity, value feelings and incentive evaluation. Advocate the development concept of "to be user-oriented, supported by technology, efficiency, value and mode leadership, and build a value chain or ecological circle " ; with excellent talents, efficient team and organizational structure to improve the enterprise to capture opportunities, operations integration, resource mining, risk identification and other development capabilities. It is hoped that management cadres at all levels will practice themselves, be strict with themselves, and vigorously advocate a truth-seeking and pragmatic work style. Management cadres will take the lead in telling the truth, doing practical things, seeking practical results, not engaging in formalism, and not making superficial articles; always maintain a spirit of forge ahead and never slack off The state of mind and the attitude of daring to break through and work, and resolutely put an end to the negative tendency of waiting, relying, relying, and demanding; vigorously advocate the work style of "to efficiency " , and resolutely put an end to the bad atmosphere of prevarication, discussion but not decision, and only saying but not doing. Vigorously advocate the work style of "raising enterprises as their own children " , put yourself in the position of seeking things, keep improving things, and strive to achieve perfection in every work; vigorously advocate "thrifty enterprise " work style, spend every penny on the blade, control every cost to the lowest, and improve the market competitiveness of enterprises and products. In his concluding speech, Jiang Xiaomeng, chairman of
Group Company, expressed his affirmation and gratitude to all enterprises for their efforts and achievements in 2021 , commented on their resource acquisition ability, team morale, internal system construction, employee centripetal force, etc., and hoped that all enterprise management teams would seriously reflect, efforts to improve the communication ability at work, the determination and responsibility of handling affairs, and be able to discover and solve problems with a more systematic thinking and a more comprehensive perspective. Jiang Xiaomeng pointed out that in the future work, "cost reduction " will always be the main tone and the most basic competitiveness for enterprises to participate in market competition. The intelligence and digitization of production enterprises for the purpose of improving labor productivity is the general trend, and we must speed up the in-depth development. Innovation work such as technological transformation and new drug research and development should be strengthened and accelerated; new investment projects need to spend more energy to accelerate. He emphasized that management teams at all levels must unify their thinking, clarify management relationships, and establish a sound system in order to better improve the team's combat effectiveness and work passion, and promote the better development of the enterprise. (Reporter Fu Yiwu)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11